FNTAP2

Across TCGA pan-cancer cohorts, FNTAP2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FNTAP2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where FNTAP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FNTAP2 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, THCA, and STAD are the cancer types where FNTAP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FNTAP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.145	.010	6	view →
THCA	Male	All	−0.150	.004	2	view →
STAD	All	All	+0.166	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

FNTAP2–COAD

Open the COAD breakdown →